Glycosaminoglycan mimicry by COAM reduces melanoma growth through chemokine induction and function

International Journal of Cancer

Volumn 131, Issue 4, 2012, Pages

  Piccard, Helene ^a   Berghmans, Nele ^a   Korpos, Eva ^b   Dillen, Chris ^a   Van Aelst, Ilse ^a   Li, Sandra ^a   Martens, Erik ^a   Liekens, Sandra ^a   Noppen, Sam ^a   Damme, Jo Van ^a   Sorokin, Lydia ^b   Opdenakker, Ghislain ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

chemokines; glycosaminoglycan mimetic; granulocyte chemotactic protein 2 CXCL6; melanoma; myeloid cells

Indexed keywords

CD11B ANTIGEN; CELL PROTEIN; CHEMOKINE; CHLORITE OXIDIZED OXYAMYLOSE; GLYCOSAMINOGLYCAN; GRANULOCYTE CHEMOTACTIC PROTEIN 2; HEPARIN; PROTEIN GR 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW CELL; CANCER SURGERY; CELL RECRUITMENT; CELLULAR PARAMETERS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DERMAL AIR POUCH; DERMIS; DISEASE MODEL; IMMUNOSTIMULATION; INOCULATION; ISOGRAFT; LYMPHOCYTOPENIA; MELANOMA; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; TUMOR VOLUME;

AMYLOSE; ANIMALS; CELL DIVISION; CHEMOKINES; FLOW CYTOMETRY; FLUORESCENT DYES; GLYCOSAMINOGLYCANS; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, NUDE; MOLECULAR MIMICRY; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84862531136     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26465     Document Type: Article

References (41)

1. Buhtoiarov IN, Sondel PM, Eickhoff JC, Rakhmilevich AL,. Macrophages are essential for antitumour effects against weakly immunogenic murine tumours induced by class B CpG-oligodeoxynucleotides. Immunology 2007; 120: 412-23. (Pubitemid 46232916)
2. Zeisberger SM, Odermatt B, Marty C, Zehnder-Fjallman AH, Ballmer-Hofer K, Schwendener RA,. Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach. Br J Cancer 2006; 95: 272-81. (Pubitemid 44187587)
3. Galarneau H, Villeneuve J, Gowing G, Julien JP, Vallieres L,. Increased glioma growth in mice depleted of macrophages. Cancer Res 2007; 67: 8874-81. (Pubitemid 47437464)
4. Pendino KJ, Meidhof TM, Heck DE, Laskin JD, Laskin DL,. Inhibition of macrophages with gadolinium chloride abrogates ozone-induced pulmonary injury and inflammatory mediator production. Am J Respir Cell Mol Biol 1995; 13: 125-32.
5. Daley JM, Thomay AA, Connolly MD, Reichner JS, Albina JE,. Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J Leukoc Biol 2008; 83: 64-70.
6. Nowicki A, Szenajch J, Ostrowska G, Wojtowicz A, Wojtowicz K, Kruszewski AA, Maruszynski M, Aukerman SL, Wiktor-Jedrzejczak W,. Impaired tumor growth in colony-stimulating factor 1 (CSF-1)-deficient, macrophage-deficient op/op mouse: evidence for a role of CSF-1-dependent macrophages in formation of tumor stroma. Int J Cancer 1996; 65: 112-9. (Pubitemid 26030942)
7. Li S, Gillessen S, Tomasson MH, Dranoff G, Gilliland DG, Van Etten RA,. Interleukin 3 and granulocyte-macrophage colony-stimulating factor are not required for induction of chronic myeloid leukemia-like myeloproliferative disease in mice by BCR/ABL. Blood 2001; 97: 1442-50. (Pubitemid 32183771)
8. Noffz G, Qin Z, Kopf M, Blankenstein T,. Neutrophils but not eosinophils are involved in growth suppression of IL-4-secreting tumors. J Immunol 1998; 160: 345-50. (Pubitemid 28116748)
9. Vajdic CM, van Leeuwen MT,. What types of cancers are associated with immune suppression in HIV? Lessons from solid organ transplant recipients. Curr Opin HIV AIDS 2009; 4: 35-41.
10. Billiau A, Desmyter J, De Somer P,. Antiviral activity of chlorite-oxidized oxyamylose, a polyacetal carboxylic acid. J Virol 1970; 5: 321-8.
11. Li S, Martens E, Dillen C, Van den Steen PE, Opdenakker G,. Virus entry inhibition by chlorite-oxidized oxyamylose versus induction of antiviral interferon by poly(I:C). Biochem Pharmacol 2008; 76: 831-40.
12. Li S, Starckx S, Martens E, Dillen C, Lamerant-Fayel N, Berghmans N, Gouwy M, van Pel M, Heremans H, Kieda C, Fibbe WE, Billiau A, et al. Myeloid cells are tunable by a polyanionic polysaccharide derivative and co-determine host rescue from lethal virus infection. J Leukoc Biol 2010; 88: 1017-29.
13. Claes P, Billiau A, De Clercq E, Desmyter J, Schonne E, Vanderhaeghe H, De Somer P,. Polyacetal carboxylic acids: a new group of antiviral polyanions. J Virol 1970; 5: 313-20.
14. Giulietti A, Overbergh L, Valckx D, Decallonne B, Bouillon R, Mathieu C,. An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 2001; 25: 386-401. (Pubitemid 34164011)
15. Livak KJ, Schmittgen TD,. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-8. (Pubitemid 34164012)
16. Kirchgessner CU, Patil CK, Evans JW, Cuomo CA, Fried LM, Carter T, Oettinger MA, Brown JM,. DNA-dependent kinase (p350) as a candidate gene for the murine SCID defect. Science 1995; 267: 1178-83.
17. Wuyts A, Haelens A, Opdenakker G, Proost P, Van Damme J,. Identification of mouse granulocyte chemotactic protein-2 from fibroblasts and epithelial cells. Functional comparison with natural KC and macrophage inflammatory protein-2. J Immunol 1996; 157: 1736-43. (Pubitemid 126449118)
18. Wuyts A, Proost P, Froyen G, Haelens A, Billiau A, Opdenakker G, Van Damme J,. Purification and identification of human and mouse granulocyte chemotactic protein-2 isoforms. Methods Enzymol 1997; 287: 13-33. (Pubitemid 27430230)
19. Antachopoulos CT, Iliopoulos DC, Gagos S, Agapitos MV, Karayannacos PE, Roboli SK, Skalkeas GD,. In vitro effects of heparin on SW480 tumor cell-matrix interaction. Anticancer Res 1995; 15: 1411-6.
20. Bobek V, Kovarik J,. Antitumor and antimetastatic effect of warfarin and heparins. Biomed Pharmacother 2004; 58: 213-9. (Pubitemid 38746746)
21. Liekens S, De Clercq E, Neyts J,. Angiogenesis: regulators and clinical applications. Biochem Pharmacol 2001; 61: 253-70. (Pubitemid 32126663)
22. Folkman J, Langer R, Linhardt RJ, Haudenschild C, Taylor S,. Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone. Science 1983; 221: 719-25. (Pubitemid 13030626)
23. Chen JL, Hong J, Lu JL, Chen MX, Chen WX, Zhu JS, Chen NW, Chen GQ, Geng JG,. Effect of non-anticoagulant N-desulfated heparin on expression of vascular endothelial growth factor, angiogenesis and metastasis of orthotopic implantation of human gastric carcinoma. World J Gastroenterol 2007; 13: 457-61. (Pubitemid 46178984)
24. Billiau A, Muyembe JJ, De Somer P,. Effect of chlorite-oxidized oxyamylose on influenza virus infection in mice. Appl Microbiol 1971; 21: 580-4.
25. De Clercq E, De Somer P,. Effect of chlorite-oxidized oxyamylose on Moloney sarcoma virus-induced tumor formation in mice. Eur J Cancer 1972; 8: 535-40.
26. Struyf S, Burdick MD, Peeters E, Van den Broeck K, Dillen C, Proost P, Van Damme J, Strieter RM,. Platelet factor-4 variant chemokine CXCL4L1 inhibits melanoma and lung carcinoma growth and metastasis by preventing angiogenesis. Cancer Res 2007; 67: 5940-8. (Pubitemid 46985030)
27. Johnson Z, Proudfoot AE, Handel TM,. Interaction of chemokines and glycosaminoglycans: a new twist in the regulation of chemokine function with opportunities for therapeutic intervention. Cytokine Growth Factor Rev 2005; 16: 625-36. (Pubitemid 41509199)
28. Handel TM, Johnson Z, Rodrigues DH, Dos Santos AC, Cirillo R, Muzio V, Riva S, Mack M, Deruaz M, Borlat F, Vitte PA, Wells TN, et al. An engineered monomer of CCL2 has anti-inflammatory properties emphasizing the importance of oligomerization for chemokine activity in vivo. J Leukoc Biol 2008; 84: 1101-8.
29. Engman CA, Zacharski LR,. Low molecular weight heparins as extended prophylaxis against recurrent thrombosis in cancer patients. J Natl Compr Canc Netw 2008; 6: 637-45.
30. Edovitsky E, Elkin M, Zcharia E, Peretz T, Vlodavsky I,. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis. J Natl Cancer Inst 2004; 96: 1219-30. (Pubitemid 39232713)
31. Li JP, Vlodavsky I,. Heparin, heparan sulfate and heparanase in inflammatory reactions. Thromb Haemost 2009; 102: 823-8.
32. Vlodavsky I, Eldor A, Haimovitz-Friedman A, Matzner Y, Ishai-Michaeli R, Lider O, Naparstek Y, Cohen IR, Fuks Z,. Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation. Invasion Metastasis 1992; 12: 112-27.
33. Fridlender ZG, Sun J, Kim S, Kapoor V, Cheng G, Ling L, Worthen GS, Albelda SM,. Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. Cancer Cell 2009; 16: 183-94.
34. Piccard H, Muschel R, Opdenakker G,. On the dual roles and phenotypes of neutrophils in tumor development and progression. Crit Rev Oncol Hematol, in press.
35. Verbeke H, Struyf S, Berghmans N, Van Coillie E, Opdenakker G, Uyttenhove C, Van Snick J, Van Damme J,. Isotypic neutralizing antibodies against mouse GCP-2/CXCL6 inhibit melanoma growth and metastasis. Cancer Lett 2011; 302: 54-62.
36. Gijsbers K, Gouwy M, Struyf S, Wuyts A, Proost P, Opdenakker G, Penninckx F, Ectors N, Geboes K, Van Damme J,. GCP-2/CXCL6 synergizes with other endothelial cell-derived chemokines in neutrophil mobilization and is associated with angiogenesis in gastrointestinal tumors. Exp Cell Res 2005; 303: 331-42. (Pubitemid 40126267)
37. Van Coillie E, Van Aelst I, Wuyts A, Vercauteren R, Devos R, De Wolf-Peeters C, Van Damme J, Opdenakker G,. Tumor angiogenesis induced by granulocyte chemotactic protein-2 as a countercurrent principle. Am J Pathol 2001; 159: 1405-14. (Pubitemid 32947970)
38. Joyce JA, Pollard JW,. Microenvironmental regulation of metastasis. Nat Rev Cancer 2009; 9: 239-52.
39. Yang L, Huang J, Ren X, Gorska AE, Chytil A, Aakre M, Carbone DP, Matrisian LM, Richmond A, Lin PC, Moses HL,. Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell 2008; 13: 23-35. (Pubitemid 350309741)
40. Gazzaniga S, Bravo AI, Guglielmotti A, van Rooijen N, Maschi F, Vecchi A, Mantovani A, Mordoh J, Wainstok R,. Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft. J Invest Dermatol 2007; 127: 2031-41. (Pubitemid 47075380)
41. Bronte V, Mocellin S,. Suppressive influences in the immune response to cancer. J Immunother 2009; 32: 1-11.